Data / Form D filings / CERO THERAPEUTICS HOLDINGS, INC.
CERO THERAPEUTICS HOLDINGS, INC.: Form D filings
CERO THERAPEUTICS HOLDINGS, INC., a pharmaceuticals company in South San Francisco, CA, filed 3 Form D notices with the SEC between 2024 and 2025. The latest, on May 6, 2025, reports $5 million sold of a $8 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 HASKINS WAY, SUITE 230, South San Francisco, CA, 94080
- Phone
- (650) 407-2376
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1870404
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2025 | New notice | $8,000,000 | $5,000,000 | $3,000,000 | 5 | Apr 22, 2025 | sec.gov |
| Oct 4, 2024 | New notice | $1,250,000 | $1,250,000 | 13 | Sep 26, 2024 | sec.gov | |
| Feb 23, 2024 | New notice | $10,193,654 | $10,193,654 | 46 | Feb 14, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shami G. Patel | Director | |
| Kristen Albert Pierce | Executive Officer | |
| Lindsey G. Rolfe | Director | |
| Kathleen G. LaPorte | Director | |
| Andrew Albert Kucharchuk | Executive Officer | |
| Chris Ehrlich | Executive Officer, Director | |
| Michael G. Byrnes | Director | |
| Brian G. Atwood | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of May 5, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CERO THERAPEUTICS HOLDINGS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.